Literature DB >> 7769084

Amphotropic but not atherotropic: another caveat for adenoviral gene therapy.

W Casscells, J T Willerson.   

Abstract

Mesh：

Year:  1995        PMID： 7769084      PMCID： PMC295908          DOI： 10.1172/JCI117938

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  18 in total

Review 1.  The advent of adenovirus. Gene therapy for cardiovascular disease.

Authors:  M D Schneider; B A French
Journal:  Circulation       Date:  1993-10       Impact factor: 29.690

2.  Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall. Modeling with microscopic tracer particles and verification with a recombinant adenoviral vector.

Authors:  J J Rome; V Shayani; M Y Flugelman; K D Newman; A Farb; R Virmani; D A Dichek
Journal:  Arterioscler Thromb       Date:  1994-01

3.  A novel gene delivery system using EGF receptor-mediated endocytosis.

Authors:  J Chen; S Gamou; A Takayanagi; N Shimizu
Journal:  FEBS Lett       Date:  1994-01-31       Impact factor: 4.124

Review 4.  Local drug delivery for the prevention of restenosis. Fact, fancy, and future.

Authors:  A M Lincoff; E J Topol; S G Ellis
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

5.  Making clinical grade gene therapy vectors.

Authors:  W French Anderson
Journal:  Hum Gene Ther       Date:  1994-08       Impact factor: 5.695

6.  Smooth muscle cell expression of extracellular matrix genes after arterial injury.

Authors:  S T Nikkari; H T Järveläinen; T N Wight; M Ferguson; A W Clowes
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

7.  Na(+)-H+ exchange inhibitors decrease neointimal formation after rat carotid injury. Effects on smooth muscle cell migration and proliferation.

Authors:  M Mitsuka; M Nagae; B C Berk
Journal:  Circ Res       Date:  1993-08       Impact factor: 17.367

8.  Localization of basic fibroblast growth factor in bovine endothelial cells: immunohistochemical and biochemical studies.

Authors:  Z X Yu; S Biro; Y M Fu; J Sanchez; G Smale; J Sasse; V J Ferrans; W Casscells
Journal:  Exp Cell Res       Date:  1993-02       Impact factor: 3.905

9.  Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

Authors:  H E von der Leyen; G H Gibbons; R Morishita; N P Lewis; L Zhang; M Nakajima; Y Kaneda; J P Cooke; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

10.  Expression and subcellular distribution of basic fibroblast growth factor are regulated during migration of endothelial cells.

Authors:  S Biro; Z X Yu; Y M Fu; G Smale; J Sasse; J Sanchez; V J Ferrans; W Casscells
Journal:  Circ Res       Date:  1994-03       Impact factor: 17.367
View more
  2 in total

1.  Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer.

Authors:  H Zhang; Y Yang; J L Horton; E B Samoilova; T A Judge; L A Turka; J M Wilson; Y Chen
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 2.  Autoimmunity, immunologic tolerance, and gene therapy.

Authors:  Y Chen
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.